BioSpace News Archive

Today, GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2023 financial results on Wednesday, Nov. 1, 2023. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update.

Arthrosi Therapeutics, Inc. today announced the acceptance of three poster presentations and one late breaking oral presentation at the American College of Rheumatology (ACR) Convergence 2023 meeting, being held in San Diego, CA on November 10-15, 2023.

The International Union for Conservation of Nature (IUCN), Standards and Petitions Committee has accepted the National Association for Biomedical Research (NABR) formal petition challenging the IUCN’s 2022 designation of long-tailed macaques

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has made in cash the final maturity date payment of C$51.1 million (or approximately US$37.5 million) to Computershare Trust Company of Canada as trustee for holders of Medexus’s

BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, is pleased to announce a second partnership with the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

Halozyme Therapeutics, Inc. will present the positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product co-formulated with its ENHANZE® drug delivery technology, in approximately 30 seconds, at the 13th Annual PODD: Partnership Opportunities in Drug Delivery Conference.

NovaCentrix, a global leader in conductive inks and nanomaterials, is proud to introduce its latest innovation: a new line of high-purity gold nanoparticle dispersions.

The maternal mortality rate in the United States, which has doubled in the past 20 years, is higher than in any other industrialized nation.

CymaBay Therapeutics, Inc. announced the grant of inducement awards to two employees on October 13, 2023 in connection with the employees’ commencement of employment at CymaBay.